Examine 2.0 has arrived! Learn about the new site

Coleus Forskohlii

Last Updated: August 17 2022

Coleus forskohlii is an herb used in traditional medicine that may boost Testosterone and induce fat loss, particularly in men.

Coleus Forskohlii is most often used for

Summary

Coleus forskohlii is an herb historically used in Ayurveda (Ayurvedic medicine).

Today, Coleus forskohlii is used as a fat burning supplement.

The main bioactive ingredient in Coleus forskohlii is called forskolin. Through forskolin, Coleus forskohlii supplementation may increase testosterone, and protect against cancer and inflammation. Further research is needed to confirm these effects, since forskolin is most often used as a research tool in vitro, or outside the body, like in a test tube or petri dish. Forskolin may act differently inside the body.

Forskolin increases cellular levels of a molecule called cyclic adenosine monophosphate (cAMP). Elevated cAMP levels are associated with increased rates of fat loss, and can improve the effects of other fat burning compounds.

Forskolin is still being researched for its effects on testosterone and fat loss, but preliminary evidence is promising.

What else is Coleus Forskohlii known as?
Note that Coleus Forskohlii is also known as:
  • Forskolin
  • Coleonol
  • 7-Beta-acetoxy-8 13-epoxy-1-alpha 6-Beta 9-alpha-trihydroxy-labd-14-en-11-one
Dosage information

To supplement Coleus forskohlii, take 250 mg of a supplement that contains 10% forskolin, twice a day, for a 500 mg total daily dose.

Further research is needed to determine the optimal Coleus forskohlii dose.

Examine Database
References
1.^Agarwal KC, Parks RE JrForskolin: a potential antimetastatic agentInt J Cancer.(1983 Dec 15)
4.^Wang YQ, Ma JP, Pan SL, Hou AJ, Huang JMStudies on the chemical constituents of Coleus forskohliiZhong Yao Cai.(2009 Sep)
5.^Bodiwala HS, Sabde S, Mitra D, Bhutani KK, Singh IPAnti-HIV diterpenes from Coleus forskohliiNat Prod Commun.(2009 Sep)
6.^Yang QR, Wu HZ, Wang XM, Zou GA, Liu YWThree new diterpenoids from Coleus forskohlii BriqJ Asian Nat Prod Res.(2006 Jun)
7.^Shen YH, Xu YLTwo new diterpenoids from Coleus forskohliiJ Asian Nat Prod Res.(2005 Dec)
8.^Alasbahi RH, Melzig MFForskolin and derivatives as tools for studying the role of cAMPPharmazie.(2012 Jan)
9.^Shan Y, Xu L, Lu Y, Wang X, Zheng Q, Kong L, Niwa MDiterpenes from Coleus forskohlii (WILLD.) BRIQ. (Labiatae)Chem Pharm Bull (Tokyo).(2008 Jan)
10.^Shan Y, Wang X, Zhou X, Kong L, Niwa MTwo minor diterpene glycosides and an eudesman sesquiterpene from Coleus forskohliiChem Pharm Bull (Tokyo).(2007 Mar)
11.^Falé PL, Madeira PJ, Florêncio MH, Ascensão L, Serralheiro MLFunction of Plectranthus barbatus herbal tea as neuronal acetylcholinesterase inhibitorFood Funct.(2011 Feb)
13.^Xu LL, Lu J, Li WJ, Kong LYStudies on the chemical constituents in root of Coleus forskohliiZhongguo Zhong Yao Za Zhi.(2005 Nov)
14.^Burns TW, Langley PE, Terry BE, Bylund DB, Forte LR JrComparative effects of forskolin and isoproterenol on the cyclic AMP content of human adipocytesLife Sci.(1987 Jan 12)
16.^Iwatsubo K, Tsunematsu T, Ishikawa YIsoform-specific regulation of adenylyl cyclase: a potential target in future pharmacotherapyExpert Opin Ther Targets.(2003 Jun)
17.^Hanoune J, Defer NRegulation and role of adenylyl cyclase isoformsAnnu Rev Pharmacol Toxicol.(2001)
18.^Litosch I, Hudson TH, Mills I, Li SY, Fain JNForskolin as an activator of cyclic AMP accumulation and lipolysis in rat adipocytesMol Pharmacol.(1982 Jul)
20.^Costford SR, Bajpeyi S, Pasarica M, Albarado DC, Thomas SC, Xie H, Church TS, Jubrias SA, Conley KE, Smith SRSkeletal muscle NAMPT is induced by exercise in humansAm J Physiol Endocrinol Metab.(2010 Jan)
21.^Dubey MP, Srimal RC, Nityanand S, Dhawan BNPharmacological studies on coleonol, a hypotensive diterpene from Coleus forskohliiJ Ethnopharmacol.(1981 Jan)
22.^Liu ZJ, Jiang DB, Tian LL, Yin JJ, Huang JM, Weng WYIntestinal Permeability of Forskolin by In Situ Single Pass Perfusion in RatsPlanta Med.(2012 Mar 12)
23.^Mante S1, Minneman KPCaffeine inhibits forskolin-stimulated cyclic AMP accumulation in rat brainEur J Pharmacol.(1990 Jan 10)
26.^Fredholm BB, Jonzon B, Lindström KEffect of adenosine receptor agonists and other compounds on cyclic AMP accumulation in forskolin-treated hippocampal slicesNaunyn Schmiedebergs Arch Pharmacol.(1986 Feb)
29.^Henderson S, Magu B, Rasmussen C, Lancaster S, Kerksick C, Smith P, Melton C, Cowan P, Greenwood M, Earnest C, Almada A, Milnor P, Magrans T, Bowden R, Ounpraseuth S, Thomas A, Kreider RBEffects of coleus forskohlii supplementation on body composition and hematological profiles in mildly overweight womenJ Int Soc Sports Nutr.(2005 Dec 9)
32.^Martin LF, Klim CM, Vannucci SJ, Dixon LB, Landis JR, LaNoue KFAlterations in adipocyte adenylate cyclase activity in morbidly obese and formerly morbidly obese humansSurgery.(1990 Aug)
34.^Filippa N, Sable CL, Filloux C, Hemmings B, Van Obberghen EMechanism of protein kinase B activation by cyclic AMP-dependent protein kinaseMol Cell Biol.(1999 Jul)
39.^Richmond SR, Touchberry CD, Gallagher PMForskolin attenuates the action of insulin on the Akt-mTOR pathway in human skeletal muscleAppl Physiol Nutr Metab.(2009 Oct)
42.^Cooke DW, Lane MDTranscription factor NF1 mediates repression of the GLUT4 promoter by cyclic-AMPBiochem Biophys Res Commun.(1999 Jul 14)
44.^Sparks LM, Moro C, Ukropcova B, Bajpeyi S, Civitarese AE, Hulver MW, Thoresen GH, Rustan AC, Smith SRRemodeling lipid metabolism and improving insulin responsiveness in human primary myotubesPLoS One.(2011)
47.^Baar K, Wende AR, Jones TE, Marison M, Nolte LA, Chen M, Kelly DP, Holloszy JOAdaptations of skeletal muscle to exercise: rapid increase in the transcriptional coactivator PGC-1FASEB J.(2002 Dec)
48.^Seldin MM, Peterson JM, Byerly MS, Wei Z, Wong GWMyonectin (CTRP15), a Novel Myokine That Links Skeletal Muscle to Systemic Lipid HomeostasisJ Biol Chem.(2012 Apr 6)
49.^Mulhall JP, Daller M, Traish AM, Gupta S, Park K, Salimpour P, Payton TR, Krane RJ, Goldstein IIntracavernosal forskolin: role in management of vasculogenic impotence resistant to standard 3-agent pharmacotherapyJ Urol.(1997 Nov)
54.^Goldberg JL1, Espinosa JS, Xu Y, Davidson N, Kovacs GT, Barres BARetinal ganglion cells do not extend axons by default: promotion by neurotrophic signaling and electrical activityNeuron.(2002 Feb 28)
61.^Vetrugno M1, Uva MG, Russo V, Iester M, Ciancaglini M, Brusini P, Centofanti M, Rossetti LMOral administration of forskolin and rutin contributes to intraocular pressure control in primary open angle glaucoma patients under maximum tolerated medical therapyJ Ocul Pharmacol Ther.(2012 Oct)
62.^Virgona N, Yokotani K, Yamazaki Y, Shimura F, Chiba T, Taki Y, Yamada S, Shinozuka K, Murata M, Umegaki KColeus forskohlii extract induces hepatic cytochrome P450 enzymes in miceFood Chem Toxicol.(2012 Mar)
65.^Haider SGCell biology of Leydig cells in the testisInt Rev Cytol.(2004)
67.^Hsu CC, Tsai SJ, Huang YL, Huang BMRegulatory mechanism of Cordyceps sinensis mycelium on mouse Leydig cell steroidogenesisFEBS Lett.(2003 May 22)
69.^De Vries GW, Amdahl LD, Lowe N, Wheeler LAEffect of forskolin on beta-adrenergic hyporesponsiveness in skinSkin Pharmacol.(1988)
72.^Lafontan M, Langin DLipolysis and lipid mobilization in human adipose tissueProg Lipid Res.(2009 Sep)
73.^Wellman GC, Santana LF, Bonev AD, Nelson MTRole of phospholamban in the modulation of arterial Ca(2+) sparks and Ca(2+)-activated K(+) channels by cAMPAm J Physiol Cell Physiol.(2001 Sep)
74.^Jeffries O, McGahon MK, Bankhead P, Lozano MM, Scholfield CN, Curtis TM, McGeown JGcAMP/PKA-dependent increases in Ca Sparks, oscillations and SR Ca stores in retinal arteriolar myocytes after exposure to vasopressinInvest Ophthalmol Vis Sci.(2010 Mar)
75.^Jones SB, Toews ML, Turner JT, Bylund DBAlpha 2-adrenergic receptor-mediated sensitization of forskolin-stimulated cyclic AMP productionProc Natl Acad Sci U S A.(1987 Mar)
77.^[No authors listedColeus forskohlii. MonographAltern Med Rev.(2006 Mar)